School of Medicine


Showing 41-43 of 43 Results

  • Susan M. Swetter, MD

    Susan M. Swetter, MD

    Professor of Dermatology

    Current Research and Scholarly Interests1) Early detection of melanoma through enhanced screening, novel imaging technologies, and professional/public education to improve melanoma awareness. 2) Therapeutic prevention of melanoma and other skin cancers in high-risk groups. 4) Epidemiologic and sociodemographic melanoma risk factors. 4) Dermatologist liaison to ECOG-ACRIN Melanoma Committee and Co-founder/Co-Director of the national Melanoma Prevention Working Group, an interdisciplinary collaboration dedicated to melanoma control.

  • Hua Tang

    Hua Tang

    Professor of Genetics and, by courtesy, of Statistics

    Current Research and Scholarly InterestsDevelop statistical and computational methods for population genomics analyses; modeling human evolutionary history; genetic association studies in admixed populations.

  • John Witte

    John Witte

    Professor of Epidemiology and Population Health, of Biomedical Data Science and, by courtesy, of Genetics

    BioDr. Witte joined the Stanford community in July 2021. In addition to serving as Vice Chair and professor in the Department of Epidemiology & Population Health, and as a professor of Biomedical Data Science and, by courtesy, of Genetics, he will also serve as a member of the Stanford Cancer Institute.

    Dr. Witte is an internationally recognized expert in genetic epidemiology. His scholarly contributions include deciphering the genetic and environmental basis of prostate cancer and developing widely used methods for the genetic epidemiologic study of disease. His prostate cancer work has used comprehensive genome-wide studies of germline genetics, transcriptomics, and somatic genomics to successfully detect novel variants underlying the risk and aggressiveness of this common disease. A key aspect of this work has been distinguishing genetic factors that may drive increased prostate cancer risk and mortality among African American men. Providing an avenue to determine which men are more likely to be diagnosed with clinically relevant prostate cancer and require additional screening or specific treatment can help reduce disparities in disease prevalence and outcomes across populations. Dr. Witte has also developed novel hierarchical and polygenic risk score modeling for undertaking genetic epidemiology studies. These advances significantly improve our ability to detect disease-causing genes and to translate genetic epidemiologic findings into medical practice.

    Dr. Witte has received the Leadership Award from the International Genetic Epidemiology Society (highest award), and the Stephen B. Hulley Award for Excellence in Teaching. His extensive teaching portfolio includes a series of courses in genetic and molecular epidemiology. He has mentored over 50 graduate students and postdoctoral fellows, serves on the executive committees of multiple graduate programs, and has directed a National Institutes of Health funded post-doctoral training program in genetic epidemiology for over 20 years. Recently appointed to the National Cancer Institute Board of Scientific Counselors, Dr. Witte has been continuously supported by the National Institutes of Health.